Methylation Effects of COV-19 Infection and Vaccinations
NCT04939155 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2021-06-30
Summary
This is a retrospective non-randomized clinical study of 60 patients total to assess the effects of SARS-CoV-2 infection and the SARS-CoV-2 vaccination. This study will have 2 arms evaluating the epigenomes of patients pre and post-exposure to one of the interventions. The first arm of the study will analyze 40 patients' epigenomes whose DNA methylation was examined pre and post SARS-CoV-2 infection. The second arm of this study is analyzing 20 patients' epigenomes whose DNA methylation was examined pre and post-injection of the SARS-CoV-2 vaccine.
Conditions
- Covid19
Interventions
- BIOLOGICAL
-
SARS-CoV-2 mRNA vaccine
mRNA vaccine for COVID
Sponsors & Collaborators
- collaborator OTHER
-
TruDiagnostic
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-10
- Primary Completion
- 2021-10-01
- Completion
- 2022-03-10
Countries
- United States
Study Locations
More Related Trials
-
Immune Responses to COVID-19 Infection or Vaccination
NCT05379478 ·Status: COMPLETED
-
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults
NCT04715997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult
NCT04695652 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)
NCT05433194 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults
NCT04614948 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older
NCT04904549 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Clinical Impact of Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO)
NCT05595031 ·Status: UNKNOWN
-
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
NCT05329220 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
NCT04927065 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years
NCT05522829 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction
NCT05212610 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19
NCT04487210 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines
NCT05434585 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older
NCT04652102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine
NCT05652543 ·Status: COMPLETED ·Phase: PHASE2
-
Study of COVID-19 DNA Vaccine (AG0302-COVID19)
NCT04527081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults
NCT05272605 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of NVX-CoV2705
NCT07086222 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study
NCT05048849 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
NCT05960097 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease
NCT01502358 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
NCT05004181 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
NCT04412538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection
NCT04666441 ·Status: COMPLETED ·Phase: PHASE2
-
Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.
NCT05385991 ·Status: COMPLETED ·Phase: PHASE1